SCHEMBL28825482

SCHEMBL28825482

COc1cncc(Cn2ccc(-c3ccc(OC(F)F)c(Cl)c3)n2)c1

nearest known ligand 0.51

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
GRIN2B Q13224 16/20 0.51
GRIN1 Q05586 11/20 0.51
KDM1A O60341 1/20 0.39
HDAC1 Q13547 1/20 0.39
HDAC2 Q92769 1/20 0.39
HDAC8 Q9BY41 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
HDAC5 Q9UQL6 1/20 0.39
KCNH2 Q12809 5/20 0.39
KDM4E B2RXH2 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28825488 0.89 GRIN2B (0.50) GRIN2BGRIN1KDM1AHDAC1HDAC2
SCHEMBL28825478 0.88 GRIN2B (0.49) GRIN2BGRIN1KCNH2KDM4ETDP1
SCHEMBL28825518 0.88 GRIN2B (0.48) GRIN2BGRIN1KCNH2KDM4ETDP1
SCHEMBL28825538 0.87 GRIN2B (0.48) GRIN2BGRIN1KCNH2KDM4ETDP1
SCHEMBL28825464 0.86 GRIN2B (0.50) GRIN2BGRIN1KDM1AHDAC1HDAC2
SCHEMBL28825556 0.85 GRIN2B (0.54) GRIN2BGRIN1KDM1AHDAC1HDAC2
SCHEMBL28825508 0.83 GRIN2B (0.47) GRIN2BGRIN1KDM1AHDAC1HDAC2
SCHEMBL28949561 0.79 GRIN2B (0.54) GRIN2BGRIN1KDM1AHDAC1HDAC2
SCHEMBL28694730 0.79 GRIN2B (0.52) GRIN2BGRIN1KDM1AHDAC1HDAC2
SCHEMBL28964548 0.76 SMN1; SMN2 (0.47) GRIN2BGRIN1KCNH2KDM4EL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114007610-A Substituted heteroaromatic pyrazolopyridines and their use as modulators of the GLUN2B receptor 詹森药业有限公司 2022-02-01 CN claimed
CN-114007610-A Substituted heteroaromatic pyrazolopyridines and their use as modulators of the GLUN2B receptor 詹森药业有限公司 2022-02-01 CN disclosed